Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis

Pigment Cell Melanoma Res. 2023 Sep;36(5):423-430. doi: 10.1111/pcmr.13103. Epub 2023 Jun 19.

Abstract

In the last decades, the concept of adipose organ has emerged, giving adipose tissue an active endocrine and immunologic function through the secretion of multiple cytokines and chemokines that seem to be implicated in the development and progression of several cancer, including cutaneous melanoma. In this pilot experimental study, we analyzed the expression in the peritumor subcutaneous adipose tissue of the most significant adipokines involved in the processes of carcinogenesis and metastasis in a population of melanoma patients and in two control groups composed of melanocytic nevi and epidermoid cysts, respectively. We correlated the results obtained with the main disease prognostic factors observing a statistically significant increase in the expression of PAI1, LEP, CXCL1, NAMPT, and TNF-α at the level of the peritumor tissue of the melanoma samples compared to the control groups and a correlation of the same with the histopathological prognostic factor of melanoma. Our preliminary study shows that the overexpression of PAI1, LEP, CXCL1, NAMPT, and TNF-α may contribute to the growth and to the local aggressiveness of cutaneous melanoma. It opens the hypothesis of a direct oncogenic role of subcutaneous adipose tissue and adipokines in the tumorigenesis of melanoma.

Keywords: Breslow thickness; adipokines; adipose tissue; melanoma; prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipokines / metabolism
  • Humans
  • Melanoma* / genetics
  • Melanoma* / pathology
  • Melanoma, Cutaneous Malignant
  • Obesity
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / pathology
  • Tumor Necrosis Factor-alpha

Substances

  • Adipokines
  • Tumor Necrosis Factor-alpha